$114.7 M

EKSO Mkt cap, 20-Jul-2018

$2.5 M

Ekso Bionics Revenue Q1, 2018
Ekso Bionics Gross profit (Q1, 2018)767 K
Ekso Bionics Gross profit margin (Q1, 2018), %30.5%
Ekso Bionics Net income (Q1, 2018)-7.9 M
Ekso Bionics EBIT (Q1, 2018)-8.6 M
Ekso Bionics Cash, 31-Mar-201820.6 M

Ekso Bionics Revenue

Ekso Bionics revenue was $7.35 m in FY, 2017

Embed Graph

Ekso Bionics Income Statement

Annual

USDFY, 2016FY, 2017

Revenue

14.2 m7.4 m

Cost of goods sold

11.3 m5.3 m

Gross profit

2.9 m2.1 m

Gross profit Margin, %

21%28%

Sales and marketing expense

11 m13.2 m

R&D expense

8.9 m9.5 m

General and administrative expense

10.9 m10.7 m

Operating expense total

30.7 m33.7 m

EBIT

(27.6 m)(31.6 m)

EBIT margin, %

(194%)(430%)

Interest expense

16 k648 k

Interest income

12 k

Net Income

(23.5 m)(29.1 m)

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Revenue

1.2 m1.6 m1.7 m2.1 m2.9 m8.5 m1.6 m1.6 m1.4 m2.5 m

Cost of goods sold

1.2 m1.1 m1.3 m1.6 m2.4 m7 m1.3 m1.2 m1.1 m1.8 m

Gross profit

45.6 k479.8 k403 k502 k468 k1.5 m203 k403 k352 k767 k

Gross profit Margin, %

4%30%24%24%16%18%13%25%25%30%

Sales and marketing expense

1.8 m1.6 m1.9 m2.5 m2.4 m2.5 m2.9 m2.7 m3.1 m3.9 m

R&D expense

698.9 k1.1 m983 k1.7 m1.7 m2.1 m2.2 m2.2 m2.9 m1.8 m

General and administrative expense

1.8 m1.5 m1.7 m1.9 m1.6 m3.5 m2.5 m2.3 m2.6 m3.7 m

Operating expense total

4.4 m4.2 m4.5 m6.1 m5.6 m8.1 m7.6 m7.3 m8.5 m9.4 m

EBIT

(4.3 m)(3.7 m)(4.1 m)(5.6 m)(5.2 m)(6.6 m)(7.4 m)(6.9 m)(8.1 m)(8.6 m)

EBIT margin, %

(360%)(235%)(242%)(267%)(178%)(78%)(477%)(430%)(567%)(342%)

Interest expense

3.8 k2.4 k3 k3 k4 k163 k

Interest income

1.5 k1 k4 k3 k2 k

Net Income

56.1 m12 m(4.1 m)(5.6 m)(5.2 m)(3.7 m)(5.8 m)(8.5 m)(8.3 m)(7.9 m)

Ekso Bionics Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

25.2 m19.6 m16.8 m27.8 m

Accounts Receivable

Inventories

388 k436 k1.6 m3 m

Current Assets

29.3 m25.2 m20.7 m34.9 m

PP&E

2.1 m2.6 m2.4 m2.2 m

Goodwill

189 k189 k189 k

Total Assets

33.5 m32.2 m24.4 m38 m

Accounts Payable

783 k2.7 m1.9 m2.4 m

Short-term debt

Current Liabilities

6.6 m8.6 m6.3 m9.2 m

Long-term debt

Total Liabilities

17.9 m16.6 m

Additional Paid-in Capital

94.5 m100.1 m121.3 m165.8 m

Retained Earnings

(71.8 m)(91.4 m)(114.9 m)(144.2 m)

Total Equity

22.8 m8.8 m6.5 m21.4 m

Financial Leverage

1.5 x3.7 x3.7 x1.8 x

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Cash

11 m7.2 m21.1 m16.3 m11.2 m12.3 m4.7 m12.8 m9.4 m20.6 m

Accounts Receivable

1.5 m1.9 m1.5 m2.4 m2.2 m2.4 m1.6 m2.2 m1.3 m

Inventories

1.3 m864.4 k838 k1.2 m1.2 m2.5 m2.4 m1.9 m1.8 m2.8 m

Current Assets

15.3 m11.7 m25.6 m22.2 m17.2 m18.2 m9.4 m17.6 m13.3 m27.9 m

PP&E

1.8 m2 m2.2 m2.2 m2.4 m2.6 m2.6 m2.6 m2.5 m2.4 m

Goodwill

189 k189 k189 k189 k189 k

Total Assets

18.6 m15.4 m30 m26.9 m22.1 m22.6 m13.6 m21.6 m16.9 m31 m

Accounts Payable

1.2 m1.1 m1.5 m2.3 m2.1 m3.6 m2.1 m1.4 m2.9 m3.4 m

Current Liabilities

6.1 m5.9 m6.7 m8.4 m8.3 m7.8 m5.8 m5.5 m7 m10 m

Total Liabilities

16.1 m

Additional Paid-in Capital

45.5 m45.6 m94.9 m95.4 m95.9 m101.7 m102.3 m117.5 m121.9 m167.4 m

Retained Earnings

(63.7 m)(51.6 m)(75.9 m)(81.6 m)(86.7 m)(95 m)(100.8 m)(109.3 m)(123.3 m)(152.1 m)

Total Equity

(18.1 m)(5.9 m)19.1 m13.9 m9.2 m6.8 m1.6 m8.2 m(1.4 m)14.8 m

Financial Leverage

-1 x-2.6 x1.6 x1.9 x2.4 x3.3 x8.7 x2.6 x-12.2 x2.1 x

Ekso Bionics Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(33.8 m)(19.6 m)(23.5 m)(29.1 m)

Depreciation and Amortization

745 k933 k1.9 m1.7 m

Accounts Receivable

(1 m)(520 k)154 k(1.1 m)

Inventories

354 k(200 k)(541 k)(2.1 m)

Accounts Payable

(716 k)1.7 m(818 k)77 k

Cash From Operating Activities

(15 m)(18.3 m)(25 m)(31.2 m)

Cash From Investing Activities

(1.5 m)(1.5 m)(1.1 m)(456 k)

Short-term Borrowings

(2.6 m)(60 k)(79 k)

Long-term Borrowings

(54 k)

Cash From Financing Activities

40.9 m14.1 m23.3 m42.6 m

Interest Paid

138 k12 k16 k429 k

Income Taxes Paid

38 k5 k33 k20 k

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

56.1 m12 m(4.1 m)(5.6 m)(5.2 m)(3.7 m)(5.8 m)(8.5 m)(8.3 m)(7.9 m)

Depreciation and Amortization

428 k

Accounts Receivable

1.5 m1.9 m1.5 m2.4 m2.2 m2.4 m1.6 m2.2 m1.3 m(798 k)

Inventories

(286 k)

Accounts Payable

1.2 m1.1 m1.5 m2.3 m2.1 m3.6 m2.1 m1.4 m2.9 m1 m

Cash From Operating Activities

(6.7 m)

Purchases of PP&E

(31 k)

Cash From Investing Activities

(31 k)

Cash From Financing Activities

(399 k)

Ekso Bionics Ratios

USDY, 2018

Financial Leverage

2.1 x
Report incorrect company information